Look for:

Products

ATAI LIFE SCIENCES BV


ISIN:
NL0015000DX5
WKN:
N0731H103

2024/07/17 21:23:08
Price
1.59 USD
Difference -3.05% (-0.05)

General attributes

ISINNL0015000DX5
SymbolATAI
ExchangeNasdaq
CurrencyUSD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)252 EUR
BenchmarkGERMANY DAX

Market data

Bid (Bid size)1.58 USD (2,700)
Ask (Ask size)1.59 USD (2,400)
Open1.62 USD
High1.67 USD
Low1.54 USD
Close (prev. day)1.64 USD
VWAP1.594808 USD
Volume (pcs)834,178
Trading volume1,330,621.82
Number of trades4,782
Last size393

Futures and Options

Related Futures-
Related Options-

PDF Downloads

Company report: ATAI LIFE SCIENCES BVPDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research



2024/07/17 21:23:08
Price
1.59 USD
Difference -3.05% (-0.05)

General attributes

ISINNL0015000DX5
SymbolATAI
ExchangeNasdaq
CurrencyUSD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)252 EUR
BenchmarkGERMANY DAX

Market data

Bid (Bid size)1.58 USD (2,700)
Ask (Ask size)1.59 USD (2,400)
Open1.62 USD
High1.67 USD
Low1.54 USD
Close (prev. day)1.64 USD
VWAP1.594808 USD
Volume (pcs)834,178
Trading volume1,330,621.82
Number of trades4,782
Last size393

Performance and Risk

6m1Y3Y
Perf (%)-11.83%-18.81%-90.56%
Perf (abs.)-0.22-0.38-15.74
Beta1.611.420.99
Volatility83.1383.8983.34
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)1.51 USD (988,536)
Ø price 30 days | Ø volume 30 days (pcs.)1.38 USD (907,748)
Ø price 100 days | Ø volume 100 days (pcs.)1.77 USD (1,317,760)
Ø price 250 days | Ø volume 250 days (pcs.)1.62 USD (1,061,406)
YTD High | date2.85 USD (2024/04/04)
YTD Low | date1.25 USD (2024/06/20)
52 Weeks High | date2.85 USD (2024/04/04)
52 Weeks Low | date1.02 USD (2023/12/01)

Arbitrage views

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Berlin2024/07/1708:081.474 EUR0.001
Duesseldorf2024/07/1719:321.409 EUR0.005
Frankfurt2024/07/1708:261.5005 EUR0.001
Munich2024/07/1708:011.494 EUR0.001
Nasdaq2024/07/1721:231.59 USD1.334,782
Stuttgart2024/07/1721:141.43 EUR0.007
Tradegate2024/07/1716:571.449 EUR0.0113
Xetra2024/07/1717:351.4495 EUR0.002

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=153128&ID_TYPE_IMAGE_LOGO=2

Contact Details

ATAI LIFE SCIENCES NV
- -
Wallstrasse 16 - 10179 Berlin
Telefon: +49-89-2153-9035
Fax: +
E-mail: info@atai.life

PDF Downloads

Company report: ATAI LIFE SCIENCES BVPDF Download

Company Profile

ATAI Life Sciences NV is a clinical-stage biopharmaceutical company. It engages in the treatment of mental health disorders. The company was founded by Christian Angermayer, Florian Brand, Srinivas Rao and Lars Christian Wilde in June 2018 and is headquartered in Berlin, Germany.

Members of Management Board

Florian BrandChairman of Managing Board
Anne JohnsonMember of Executive Committee
Rolando Gutierrez-EsteinouMember of Executive Committee
Sahil KirpekarMember of Executive Committee
Srinivas RaoMember of Executive Committee
Stephen BardinMember of Executive Committee

Board of directors

Christian AngermayerChairman of Supervisory Board
Amir KalaliMember of Supervisory Board
Laurent FischerMember of Supervisory Board
Scott BraunsteinMember of Supervisory Board
Andrea SmileyMember of Supervisory Board
Michael AuerbachMember of Supervisory Board
Sabrina JohnsonMember of Supervisory Board





Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. Please read more information here

INFORMATION FOR CORPORATE AND INSTITUTIONAL CLIENTS

Any information, material and services regarding financial instruments and securities provided by Erste Group Bank AG or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites”) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions (the “Interested Party“).

The publication and distribution of information as well as offering and selling of products and services described on the Websites is prohibited by law in some jurisdictions. For this reason, persons in countries in which the publication as well as the offering and selling of products and services described on the Websites are not permitted by law, must not enter the Websites and/or acquire the products displayed on the Websites.

Neither Erste Group nor any third party shall offer access to the Websites or offer the products to especially, but not limited to citizen/residents of the United States and “U.S. person” (as defined in Regulation S under the US Securities Act 1933 as amended), citizen/resident of Australia, Canada, Great Britain and Japan. For this reason, the distribution or redistribution of the information, materials and products into United States, Australia, Canada, Great Britain and Japan or into any other jurisdiction where it is not permitted under the applicable law, as well as to the citizens/residents of these countries shall be prohibited.

The securities displayed on the Websites have not been and will not be registered under the US Securities Act of 1933 and trading in the securities has not been approved for purposes of the US Commodities Exchange Act of 1936. For this reason the securities may, inter alia, not be offered, sold or delivered within the United States or, for the account and benefit of U.S. persons.

The Interested Party is solely responsible to examine, whether he may enter the Websites under the law applicable to it. Erste Group shall not be responsible for the distribution of content of any of the Websites to individuals or entities which provide false information about their right to enter the Websites. For this reason Erste Group shall not be liable for any legal claims or damages which may result from the unauthorized entering or reading of the Websites.

By agreeing to this hereto, the Interested Party confirms that
(i) It has read, understood and accepted this Information and the Disclaimer;
(ii) It informed itself about any possible legal restriction and warrants that it is not restricted or prohibited to enter the Websites according to any law applicable; and
(iii) It does not make available the contents of the Websites to any person who is not qualified by law to enter the Websites.
(iV) It is no consumer.